Finbar Group Limited

FRI

Finbar Group Ltd. engages in the development of medium to high density residential apartments and commercial property. The company is headquartered in Perth, Western Australia. The firm is focused on the development of medium to high-density residential buildings and commercial developments in Western Australia by way of direct ownership, ownership through fully owned subsidiaries or by equity accounted investees. Its segments include Residential Apartment Development, Commercial Office/Retail development, and Rental of Property. Its segments are all located in West Australia. The Company’s completed projects include AT238, Vue Tower, One Kennedy, Dianella Apartments and REVA. Its under construction projects include Civic Heart, Aurora Applecross and The Point. The firm holds its rental properties through 175 Adelaide Terrace Pty Ltd, 31 Rowe Avenue Pty Ltd, 32 Riversdale Road Pty Ltd, 36 Chester Avenue Pty Ltd, 43 McGregor Road Pty Ltd, 5-7 Harper Terrace Pty Ltd, Finbar Karratha Pty Ltd and Finbar Commercial Pty Ltd.

Farm Pride Foods Limited

FRM

Farm Pride Foods Ltd. engages in the provision of consumer goods, which includes the production, processing, and selling of egg and egg related products such as egg white, egg yolk, scrambled egg, fried eggs, crepes. The company is headquartered in Melbourne, Victoria. The firm farms, processes and markets a range of egg and egg-related products. The firm develops its farming business to meet the requirement for cage-free eggs. The company maintains relationships in the supermarket channel and with industrial food manufacturers. Along with its range of fresh eggs, found in supermarkets across the eastern seaboard, the Company also manufactures egg products at its Keysborough Processing Plant. The company supplies all commercial markets, including the airline, hotel and restaurant industries among others, with its range of egg products. The firm manufactures its own egg cartons using recycled newsprint and cardboard. The firm offers egg products, such as whole eggs, egg white, egg yolk, scrambled eggs, peeled boiled eggs, fried eggs, omelets and egg cartoons. The firm sources its fresh eggs from its own farms and local suppliers across the country.

Firebird Metals Limited

FRB

Firebird Metals Ltd. engages in the exploration and development of mineral properties. The firm is focused on combining mining and downstream processing for the advancement of the electric vehicle (EV) battery sector. Its projects include Oakover Manganese Project, Wandanya Project and Hill 616 Manganese Project. The Oakover Manganese Project is located approximately 85 kilometers (kms) east of Newman in the Eastern Pilbara region of Western Australia and about 100 kms south of the Ant Hill manganese deposit and about 50 kms from the Nicholas Downs manganese deposit. The Hill 616 Manganese Project is located over 85 kms southeast of Newman within the Peak Hill Mineral Field. Wandanya Project consists of two exploration license applications E46/1456 and E46/1457, which cover an area of 51 square kilometers (Km2) located in the Eastern Pilbara Region of Western Australia. Its other projects include Disraeli Manganese Project, Midgengadge Manganese Project and Raggard Hills Manganese Project.

Firebrick Pharma Limited

FRE

Firebrick Pharma Ltd. is a pharmaceutical company, which engages in the development and commercialization of nasal spray treatment for the common cold based around the potential of povidone-iodine as an antimicrobial agent. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The principal activity for the Company is the clinical development and partnering of Nasodine, a broad-spectrum antimicrobial spray for the treatment of the common cold. The firm has developed a povidone-iodine nasal spray, called Nasodine Nasal Spray and filed international trademarks and multiple patents on the product, including a formulation patent and two use patents, some of which have already been granted in the United States, Europe and Australia. The firm has also completed six clinical trials for Nasodine, including a Phase I study, three Phase II studies and two Phase III studies, which have affirmed the product’s safety and generally supported its efficacy as an antimicrobial nasal spray with utility in a range of clinical settings. Nasodine Phase II COVID-19 trail achieves primarily endpoints.